+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas



Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas



International Journal of Radiation Oncology, Biology, Physics 76(1): 193-200



To evaluate the outcomes of patients with vestibular schwannoma (VS) treated with fractionated stereotactic radiotherapy (FSRT) vs. those treated with stereotactic radiosurgery (SRS). This study is based on an analysis of 200 patients with 202 VSs treated with FSRT (n = 172) or SRS (n = 30). Patients with tumor progression and/or progression of clinical symptoms were selected for treatment. In 165 out of 202 VSs (82%), RT was performed as the primary treatment for VS, and for 37 VSs (18%), RT was conducted for tumor progression after neurosurgical intervention. For patients receiving FSRT, a median total dose of 57.6 Gy was prescribed, with a median fractionation of 5 x 1.8 Gy per week. For patients who underwent SRS, a median single dose of 13 Gy was prescribed to the 80% isodose. FSRT and SRS were well tolerated. Median follow-up time was 75 months. Local control was not statistically different for both groups. The probability of maintaining the pretreatment hearing level after SRS with doses of < or =13 Gy was comparable to that of FSRT. The radiation dose for the SRS group (< or =13 Gy vs. >13 Gy) significantly influenced hearing preservation rates (p = 0.03). In the group of patients treated with SRS doses of < or =13 Gy, cranial nerve toxicity was comparable to that of the FSRT group. FSRT and SRS are both safe and effective alternatives for the treatment of VS. Local control rates are comparable in both groups. SRS with doses of < or =13 Gy is a safe alternative to FSRT. While FSRT can be applied safely for the treatment of VSs of all sizes, SRS should be reserved for smaller lesions.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052601618

Download citation: RISBibTeXText

PMID: 19604653

DOI: 10.1016/j.ijrobp.2009.01.064


Related references

Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannomas: comparative observations of 139 patients treated at a single institution. Journal of Radiation Research 55(2): 351-358, 2015

Single institution experience with 110 patient treated for acoustic schwannomas Analysis of Gamma Knife stereotactic radiosurgery and Linac fractionated stereotactic radiotherapy. International Journal of Radiation Oncology Biology Physics 48(3 Suppl.): 254, 2000

Single fraction versus fractionated linac based stereotactic radiosurgery for vestibular schwannoma; a single institutional study. International Journal of Radiation Oncology Biology Physics 54(2 Suppl.): 144, 2002

Stereotactic fractionated radiotherapy and LINAC radiosurgery in the treatment of vestibular schwannoma-report about both stereotactic methods from a single institution. International Journal of Radiation Oncology, Biology, Physics 80(5): 1485-1491, 2011

Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience. International Journal of Radiation Oncology, Biology, Physics 81(4): E503-E509, 2012

Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: A single-institution study. International Journal of Radiation Oncology Biology Physics 56(5): 1390-1396, August 1, 2003

Stereotactic radiosurgery and fractionated stereotactic radiosurgery for vestibular schwannomas: A comparison of clinical outcomes from the RSSearch patient registry. Journal of Radiosurgery and Sbrt 6(1): 19-26, 2019

Stereotactic fractionated radiotherapy and linac-radiosurgery in the treatment of vestibular schwannoma. International Journal of Radiation Oncology*biology*physics 60: S313-S314, 2004

Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery. Journal of Neuro-Oncology 116(1): 187-193, 2014

Cushing's disease: a single centre's experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy. Journal of Clinical Neuroscience 21(1): 100-106, 2014

Nelson's syndrome: single centre experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy. Journal of Clinical Neuroscience 21(9): 1520-1524, 2015

Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. International Journal of Radiation Oncology Biology Physics 42(3): 573-580, Oct 1, 1998

(P019) Linac-Based Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy for Brain Metastases From Sarcoma. International Journal of Radiation Oncology*Biology*Physics 98(2): E20-E21, 2017

Frameless fractionated stereotactic radiosurgery for vestibular schwannomas: a single-institution experience. Frontiers in Oncology 3: 121, 2013

Fractionated stereotactic radiosurgery for vestibular schwannomas using cyberknife: A single institution experience. Jpma. Journal of the Pakistan Medical Association 66(9): 1089-1093, 2018